Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Virol Sin. 2020 Jun;35(3):290-304. doi: 10.1007/s12250-020-00252-z. Epub 2020 Jun 30.
The recent outbreak of coronavirus disease (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already affected a large population of the world. SARS-CoV-2 belongs to the same family of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). COVID-19 has a complex pathology involving severe acute respiratory infection, hyper-immune response, and coagulopathy. At present, there is no therapeutic drug or vaccine approved for the disease. There is an urgent need for an ideal animal model that can reflect clinical symptoms and underlying etiopathogenesis similar to COVID-19 patients which can be further used for evaluation of underlying mechanisms, potential vaccines, and therapeutic strategies. The current review provides a paramount insight into the available animal models of SARS-CoV-2, SARS-CoV, and MERS-CoV for the management of the diseases.
新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的冠状病毒病(COVID-19)疫情已在世界范围内蔓延。SARS-CoV-2 属于严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV)家族。COVID-19 的病理学复杂,涉及严重急性呼吸道感染、超免疫反应和凝血功能障碍。目前,尚无批准用于治疗该疾病的药物或疫苗。迫切需要一种理想的动物模型,该模型能够反映与 COVID-19 患者相似的临床症状和潜在发病机制,可进一步用于评估潜在的疫苗和治疗策略。目前的综述提供了有关 SARS-CoV-2、SARS-CoV 和 MERS-CoV 现有动物模型的重要见解,用于这些疾病的管理。